GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024
GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
EverGlade Consulting Helps GeoVax Secure up to $45 Million in BARDA Funding
Registration Is Now Open for Tribe Public's Webinar Event "Now Is Not the Time to Monkey(pox) Around" Featuring GeoVax Lab's CEO
GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market
WHO Declares Mpox a Public Health Emergency as Variant Emerges